Concurrent TP53 Mutation and Deletion in Refractory Low-grade Follicular Lymphoma

被引:3
|
作者
Khanlari, Mahsa [1 ]
Wang, Sa A. [1 ]
Fowler, Nathan H. [2 ]
Tang, Guilin [1 ]
Saluja, Karan [3 ]
Muzzafar, Tariq [1 ]
Medeiros, L. Jeffrey [1 ]
Thakral, Beenu [1 ]
机构
[1] MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX USA
[2] MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Div Canc Med, Houston, TX USA
[3] Univ Texas Hlth Sci Ctr Houston, Dept Pathol & Lab Med, McGovern Med Sch, Houston, TX USA
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷 / 07期
关键词
Low-grade lymphoma; TP53; Follicular lymphoma; Mutation; Deletion; P53; TRANSFORMATION; PROGRESSION; EXPRESSION; IMPACT;
D O I
10.1016/j.clml.2021.03.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
• Follicular lymphoma (FL) of low histologic grade (grade 1-2) is considered to be a clinically indolent disease. However, patients with FL can present in a heterogeneous manner and exhibit variably clinical behavior, and this heterogeneity is associated with underlying molecular and cytogenetic changes. • Understanding the prognostic factors of patients with FL early in the disease course will improve an individualized approach and guide personalized therapy. • We report a case of low-grade FL with high-risk clinical features that were not captured by its low-grade histologic features, immunophenotypic profile, and a low proliferation index as assessed by Ki67. Immunohistochemistry revealed overexpression of p53 that led to further discovery of concurrent TP53 mutation and 17p deletion in the lymphoma cells. • The presence of TP53 abnormalities in low-grade FL in the absence of morphological transformation is not well-studied. This case highlights the need for molecular and cytogenetic characterization of low-grade FLs beyond morphology-based grading and assessment of proliferation rate. © 2021 Elsevier Inc.
引用
收藏
页码:E626 / E629
页数:4
相关论文
共 50 条
  • [1] TP53 ALTERATIONS AND CLINICAL OUTCOME IN LOW-GRADE ASTROCYTOMAS
    KRAUS, JA
    BOLLN, C
    WOLF, HK
    NEUMANN, J
    KINDERMANN, D
    FIMMERS, R
    FORSTER, F
    BAUMANN, A
    SCHLEGEL, U
    [J]. GENES CHROMOSOMES & CANCER, 1994, 10 (02): : 143 - 149
  • [2] Low-grade papillary Schneiderian carcinoma with TP53 mutation: a case report and review of the literature
    Yuzawa, Sayaka
    Michizuka, Tomohiko
    Kakisaka, Rika
    Ono, Yusuke
    Hayashi, Manami
    Takahara, Miki
    Katada, Akihiro
    Mizukami, Yusuke
    Tanino, Mishie
    [J]. DIAGNOSTIC PATHOLOGY, 2023, 18 (01)
  • [3] Low-grade papillary Schneiderian carcinoma with TP53 mutation: a case report and review of the literature
    Sayaka Yuzawa
    Tomohiko Michizuka
    Rika Kakisaka
    Yusuke Ono
    Manami Hayashi
    Miki Takahara
    Akihiro Katada
    Yusuke Mizukami
    Mishie Tanino
    [J]. Diagnostic Pathology, 18
  • [4] Impact of TP53 mutation and 17p deletion in mantle cell lymphoma
    A M Halldórsdóttir
    A Lundin
    F Murray
    L Mansouri
    S Knuutila
    C Sundström
    A Laurell
    H Ehrencrona
    B Sander
    R Rosenquist
    [J]. Leukemia, 2011, 25 : 1904 - 1908
  • [5] Impact of TP53 mutation and 17p deletion in mantle cell lymphoma
    Halldorsdottir, A. M.
    Lundin, A.
    Murray, F.
    Mansouri, L.
    Knuutila, S.
    Sundstrom, C.
    Laurell, A.
    Ehrencrona, H.
    Sander, B.
    Rosenquist, R.
    [J]. LEUKEMIA, 2011, 25 (12) : 1904 - 1908
  • [6] High TP53 Mutation Load Predicts Primary Refractory Mantle Cell Lymphoma
    Obr, Ales
    Klener, Pavel, Jr.
    Kriegova, Eva
    Zemanova, Zuzana
    Urbankova, Helena
    Jirkuvova, Andrea
    Petrackova, Anna
    Cudova, Barbora
    Sedlarikova, Lenka
    Prochazka, Vit K.
    Papajik, Tomas
    Trneny, Marek
    [J]. BLOOD, 2019, 134
  • [7] A case report of low grade fetal lung adenocarcinoma with TP53 mutation
    Wang, Bo
    Jin, Huri
    [J]. MEDICINE, 2022, 101 (11)
  • [8] Rituximab for low-grade follicular lymphoma?
    Sharma, Sharan
    [J]. LANCET ONCOLOGY, 2014, 15 (11): : E476 - E476
  • [9] A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma
    Davies, AJ
    Lee, AM
    Taylor, C
    Clear, AJ
    Goff, LK
    Iqbal, S
    Cuthbert-Heavens, D
    Calaminici, M
    Norton, AJ
    Lister, TA
    Fitzgibbon, J
    [J]. LEUKEMIA, 2005, 19 (08) : 1459 - 1465
  • [10] A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma
    A J Davies
    A M Lee
    C Taylor
    A J Clear
    L K Goff
    S Iqbal
    D Cuthbert-Heavens
    M Calaminici
    A J Norton
    T A Lister
    J Fitzgibbon
    [J]. Leukemia, 2005, 19 : 1459 - 1465